Calcium ascorbate 60 mg / calcium threonate 0.8 mg / ferrous asparto glycinate 50 mg / folic acid 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg / vitamin B12 0.025 mg Oral Capsule [Ferrex 150 Forte Plus]
RxNorm 1087249

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1087249 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: calcium ascorbate 60 mg / calcium threonate 0.8 mg / ferrous asparto glycinate 50 mg / folic acid 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg / vitamin B12 0.025 mg Oral Capsule [Ferrex 150 Forte Plus].

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Calcium ascorbate 60 mg / calcium threonate 0.8 mg / ferrous asparto glycinate 50 mg / folate 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg / vitamin B12 0.025 mg Oral Capsule [Ferrex 150 Forte Plus]
AUI:12375669
View
SBD
Calcium ascorbate 60 mg / calcium threonate 0.8 mg / ferrous asparto glycinate 50 mg / folic acid 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg / vitamin B12 0.025 mg Oral Capsule [Ferrex 150 Forte Plus]
AUI:12367588
View
SY
Ferrex 150 Forte Plus (calcium ascorbate 60 mg / calcium threonate 0.8 mg / cyanocobalamin 0.025 mg / ferrous asparto glycinate 50 mg / folic acid 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg) Oral Capsule
AUI:3609300
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SYPrescribable

Synonym (SY):
Calcium ascorbate 60 mg / calcium threonate 0.8 mg / ferrous asparto glycinate 50 mg / folate 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg / vitamin B12 0.025 mg Oral Capsule [Ferrex 150 Forte Plus]
(Atom ID: 12375669)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
calcium ascorbate 60 MG / calcium threonate 0.8 MG / ferrous asparto glycinate 50 MG / folate 1 MG / polysaccharide iron complex 100 MG / succinic acid 50 MG / vitamin B12 0.025 MG Oral Capsule [Ferrex 150 Forte Plus]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1087249
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12375669
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1087249
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBDPrescribable

Semantic Branded Drug (SBD):
Calcium ascorbate 60 mg / calcium threonate 0.8 mg / ferrous asparto glycinate 50 mg / folic acid 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg / vitamin B12 0.025 mg Oral Capsule [Ferrex 150 Forte Plus]
(Atom ID: 12367588)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
calcium ascorbate 60 MG / calcium threonate 0.8 MG / ferrous asparto glycinate 50 MG / folic acid 1 MG / polysaccharide iron complex 100 MG / succinic acid 50 MG / vitamin B12 0.025 MG Oral Capsule [Ferrex 150 Forte Plus]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1087249
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12367588
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1087249
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{315966} 4511
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{317627} 11248
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{802497} 142407
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{802498} 273888
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{802499} 644718
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{802501} 37255
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{996027} 105669
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{315966} 4511
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{317627} 11248
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{802497} 1151
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{802498} 1316581
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{802499} 1541238
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{802501} 37255
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{996027} 105669
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
60 MG / 0.8 MG / 50 MG / 1 MG / 100 MG / 50 MG / 0.025 MG
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{315966} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{317627} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{802497} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{802498} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{802499} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{802501} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{996027} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Cap
The RxTerm dose form name for this drug
SYPrescribable

Synonym (SY):
Ferrex 150 Forte Plus (calcium ascorbate 60 mg / calcium threonate 0.8 mg / cyanocobalamin 0.025 mg / ferrous asparto glycinate 50 mg / folic acid 1 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg) Oral Capsule
(Atom ID: 3609300)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Ferrex 150 Forte Plus (calcium ascorbate 60 MG / calcium threonate 0.8 MG / cyanocobalamin 0.025 MG / ferrous asparto glycinate 50 MG / folic acid 1 MG / polysaccharide iron complex 100 MG / succinic acid 50 MG) Oral Capsule
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1087249
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3609300
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1087249
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Folate



[Learn More]


Vitamin B12



[Learn More]


* Please review the disclaimer below.